Synesthesia Family Exomes Lead to Rare Gene Variants
|
By LabMedica International staff writers Posted on 22 Mar 2018 |

Image: The 5500xl SOLiD genetic analyzer (Photo courtesy of Life Technologies).
Synesthesia is a neurological phenomenon that causes unusual links between sensory experiences, and its molecular basis is completely unknown. Synesthesia is a perceptual phenomenon in which stimulation of one sensory or cognitive pathway leads to automatic, involuntary experiences in a second sensory or cognitive pathway.
In many cases, color sensations are triggered by specific cues such as the sight of letters, numbers, or words, though other sensory stimuli and secondary perceptions may be linked. While past studies hinted that enhanced brain neuronal connectivity contributes to such processes, the genetic basis of these interconnections remains murkier.
An international team of scientists led by those at the Max Planck Institute for Psycholinguistics (Nijmegen, The Netherlands) identified three multi-generation families affected with auditory-visual synesthesia that linked sounds to color. To explore these pathways in one type of synesthesia, the team performed whole-exome sequencing on several affected and unaffected family members in three auditory-visual synesthesia-affected pedigrees spanning at least three generations. From nearly 11,600 suspicious variants in the families, they narrowed in on 3,864 rare variants for additional analyses.
The team further focused in on 37 rare, heterozygous mutations that tracked with synesthesia in the families and followed a dominant inheritance pattern. Although the same variants were not found across families, three of the variants were previously linked to synesthesia in autism spectrum disorder-affected families profiled. DNA was extracted from blood, buccal swabs, or Oragene kits of 18 individuals from the three selected synesthesia families. Library preparation began with 3 μg of purified DNA. Enrichment for exonic regions was performed using the SOLiD-optimized Sure Select All Human Exon Kit followed by sequencing on 5500XL Genetic Analysis System.
Consistent with reports indicating genetic heterogeneity, no variants were shared across families. Gene ontology analyses highlighted six genes: COL4A1, ITGA2, MYO10, ROBO3, SLC9A6, and SLIT2, associated with axonogenesis and expressed during early childhood when synesthetic associations are formed. Available gene- and protein expression data indicated that these genes are expressed in the human brain, particularly during development and childhood, while the investigator’s own array-based tests on six post-mortem brain samples supported the notion that the genes are expressed in parts of the brain previously implicated in synesthesia.
Amanda Katherine Tilot, PhD, the lead author of the study, said, “Brain imaging of adults with synesthesia suggests that their circuits are wired a little differently compared to people who don't make these extra sensory associations. What we don't know yet is how these differences develop. We suspect some of the answers lie in people's genetic makeup.” The study was published on March 5, 2018 in the journal Proceedings of the National Academy of Sciences.
Related Links:
Max Planck Institute for Psycholinguistics
In many cases, color sensations are triggered by specific cues such as the sight of letters, numbers, or words, though other sensory stimuli and secondary perceptions may be linked. While past studies hinted that enhanced brain neuronal connectivity contributes to such processes, the genetic basis of these interconnections remains murkier.
An international team of scientists led by those at the Max Planck Institute for Psycholinguistics (Nijmegen, The Netherlands) identified three multi-generation families affected with auditory-visual synesthesia that linked sounds to color. To explore these pathways in one type of synesthesia, the team performed whole-exome sequencing on several affected and unaffected family members in three auditory-visual synesthesia-affected pedigrees spanning at least three generations. From nearly 11,600 suspicious variants in the families, they narrowed in on 3,864 rare variants for additional analyses.
The team further focused in on 37 rare, heterozygous mutations that tracked with synesthesia in the families and followed a dominant inheritance pattern. Although the same variants were not found across families, three of the variants were previously linked to synesthesia in autism spectrum disorder-affected families profiled. DNA was extracted from blood, buccal swabs, or Oragene kits of 18 individuals from the three selected synesthesia families. Library preparation began with 3 μg of purified DNA. Enrichment for exonic regions was performed using the SOLiD-optimized Sure Select All Human Exon Kit followed by sequencing on 5500XL Genetic Analysis System.
Consistent with reports indicating genetic heterogeneity, no variants were shared across families. Gene ontology analyses highlighted six genes: COL4A1, ITGA2, MYO10, ROBO3, SLC9A6, and SLIT2, associated with axonogenesis and expressed during early childhood when synesthetic associations are formed. Available gene- and protein expression data indicated that these genes are expressed in the human brain, particularly during development and childhood, while the investigator’s own array-based tests on six post-mortem brain samples supported the notion that the genes are expressed in parts of the brain previously implicated in synesthesia.
Amanda Katherine Tilot, PhD, the lead author of the study, said, “Brain imaging of adults with synesthesia suggests that their circuits are wired a little differently compared to people who don't make these extra sensory associations. What we don't know yet is how these differences develop. We suspect some of the answers lie in people's genetic makeup.” The study was published on March 5, 2018 in the journal Proceedings of the National Academy of Sciences.
Related Links:
Max Planck Institute for Psycholinguistics
Latest Molecular Diagnostics News
- Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
- Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
- Two-in-One DNA Analysis Improves Diagnostic Accuracy While Saving Time and Costs
- “Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
- New Tool Maps Chromosome Shifts in Cancer Cells to Predict Tumor Evolution
- Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
- Newly-Identified Parkinson’s Biomarkers to Enable Early Diagnosis Via Blood Tests
- New Blood Test Could Detect Pancreatic Cancer at More Treatable Stage
- Liquid Biopsy Could Replace Surgical Biopsy for Diagnosing Primary Central Nervous Lymphoma
- New Tool Reveals Hidden Metabolic Weakness in Blood Cancers
- World's First Blood Test Distinguishes Between Benign and Cancerous Lung Nodules
- Rapid Test Uses Mobile Phone to Identify Severe Imported Malaria Within Minutes
- Gut Microbiome Signatures Predict Long-Term Outcomes in Acute Pancreatitis
- Blood Test Promises Faster Answers for Deadly Fungal Infections
- Blood Test Could Detect Infection Exposure History
- Urine-Based MRD Test Tracks Response to Bladder Cancer Surgery
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







